Significant anti-tumor effect of bevacizumab in treatment of pineal gland glioblastoma multiforme.

Mansour, Joshua; Fields, Braxton; Macomson, Samuel; Rixe, Olivier

Mansour, Joshua; Fields, Braxton; Macomson, Samuel; Rixe, Olivier.

Affiliation

Mansour J; Department of Internal Medicine, Georgia Regents University, Augusta, GA, USA.

Target Oncol ; 9(4): 395-8, 2014 Dec.

Article in En | MEDLINE | ID: mdl-24998223

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Agents/therapeutic use; Brain Neoplasms/drug therapy; Glioblastoma/drug therapy; Pineal Gland/pathology; Aged; Angiogenesis Inhibitors/therapeutic use; Bevacizumab; Brain Neoplasms/diagnostic imaging; Chemotherapy, Adjuvant; Dacarbazine/administration & dosage; Dacarbazine/analogs & derivatives; Disease Progression; Fatal Outcome; Glioblastoma/diagnostic imaging; Humans; Magnetic Resonance Imaging; Male; Pineal Gland/diagnostic imaging; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pineal Gland / Brain Neoplasms / Glioblastoma / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Limits: Aged / Humans / Male Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: United States Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google